Arga Investment Management LP Has Upped Johnson & Johnson (JNJ) Stake; Juno Therapeutics (JUNO) Shorts Down By 0.01%

June 20, 2017 - By Kurt Siggers

Juno Therapeutics Incorporated (NASDAQ:JUNO) had a decrease of 0.01% in short interest. JUNO’s SI was 16.32 million shares in June as released by FINRA. Its down 0.01% from 16.32M shares previously. With 1.51M avg volume, 11 days are for Juno Therapeutics Incorporated (NASDAQ:JUNO)’s short sellers to cover JUNO’s short positions. The SI to Juno Therapeutics Incorporated’s float is 26.9%. About 34,429 shares traded. Juno Therapeutics Inc (NASDAQ:JUNO) has declined 39.85% since June 20, 2016 and is downtrending. It has underperformed by 56.55% the S&P500.

Arga Investment Management Lp increased Johnson & Johnson (JNJ) stake by 845.45% reported in 2016Q4 SEC filing. Arga Investment Management Lp acquired 18,600 shares as Johnson & Johnson (JNJ)’s stock rose 6.85%. The Arga Investment Management Lp holds 20,800 shares with $2.40 million value, up from 2,200 last quarter. Johnson & Johnson now has $361.16B valuation. The stock rose 0.21% or $0.28 reaching $134.35 per share. About 128,814 shares traded. Johnson & Johnson (NYSE:JNJ) has risen 12.54% since June 20, 2016 and is uptrending. It has underperformed by 4.16% the S&P500.

Investors sentiment increased to 0.94 in Q4 2016. Its up 0.12, from 0.82 in 2016Q3. It improved, as 63 investors sold JNJ shares while 834 reduced holdings. 114 funds opened positions while 731 raised stakes. 1.72 billion shares or 0.88% more from 1.71 billion shares in 2016Q3 were reported. 1St Source Comml Bank reported 115,885 shares. Jpmorgan Chase And Company owns 20.69 million shares. Mechanics Retail Bank Tru Department has 94,861 shares for 2.65% of their portfolio. Meiji Yasuda Asset Mngmt reported 1.24% stake. Dillon Incorporated has invested 3.37% in Johnson & Johnson (NYSE:JNJ). Strategic Advsrs Limited Liability Co holds 60,231 shares. Shapiro Capital Management Ltd Limited Liability Company holds 4,200 shares or 0% of its portfolio. Loudon Mgmt Ltd Liability Company holds 3,761 shares. Nj State Employees Deferred Compensation Plan reported 1.14% in Johnson & Johnson (NYSE:JNJ). Calamos Wealth Mgmt Ltd Com accumulated 1.15% or 61,971 shares. Argi Invest Ltd Limited Liability Company has 12,550 shares for 0.13% of their portfolio. Rnc Mngmt Ltd Llc has 2.08% invested in Johnson & Johnson (NYSE:JNJ) for 218,199 shares. Cam Group Inc Holdg A S reported 0.71% stake. Polar Capital Ltd Liability Partnership reported 0.29% in Johnson & Johnson (NYSE:JNJ). Compton Capital Mgmt Ri has 1.49% invested in Johnson & Johnson (NYSE:JNJ) for 24,760 shares.

Among 16 analysts covering Johnson & Johnson (NYSE:JNJ), 8 have Buy rating, 1 Sell and 7 Hold. Therefore 50% are positive. Johnson & Johnson had 44 analyst reports since August 7, 2015 according to SRatingsIntel. The firm has “Hold” rating given on Tuesday, March 15 by Jefferies. Barclays Capital downgraded the shares of JNJ in report on Tuesday, November 29 to “Equal-Weight” rating. Argus Research maintained Johnson & Johnson (NYSE:JNJ) on Wednesday, April 20 with “Buy” rating. UBS maintained the shares of JNJ in report on Wednesday, October 19 with “Buy” rating. The company was downgraded on Monday, August 31 by Vetr. As per Wednesday, October 14, the company rating was maintained by S&P Research. The rating was initiated by Societe Generale on Wednesday, April 6 with “Hold”. The rating was upgraded by JP Morgan to “Overweight” on Monday, May 15. The firm has “Buy” rating given on Tuesday, September 22 by UBS. On Monday, October 5 the stock rating was reinitiated by Piper Jaffray with “Neutral”.

Since February 1, 2017, it had 0 buys, and 5 sales for $14.98 million activity. The insider Duato Joaquin sold 50,000 shares worth $6.18 million. Another trade for 22,000 shares valued at $2.58M was sold by Stoffels Paulus. $1.78M worth of Johnson & Johnson (NYSE:JNJ) was sold by Kapusta Ronald A on Tuesday, February 28. On Tuesday, February 28 the insider Pruden Gary J sold $1.99M. $2.45 million worth of Johnson & Johnson (NYSE:JNJ) was sold by Ullmann Michael H on Wednesday, February 1.

Arga Investment Management Lp decreased Barclays Plc (NYSE:BCS) stake by 60,339 shares to 84,859 valued at $933,000 in 2016Q4. It also reduced Pioneer Nat Res Co (NYSE:PXD) stake by 6,000 shares and now owns 4,300 shares. State Str Corp (NYSE:STT) was reduced too.

Among 14 analysts covering Juno Therapeutics Inc (NASDAQ:JUNO), 6 have Buy rating, 1 Sell and 7 Hold. Therefore 43% are positive. Juno Therapeutics Inc had 28 analyst reports since July 22, 2015 according to SRatingsIntel. The stock of Juno Therapeutics Inc (NASDAQ:JUNO) has “Buy” rating given on Friday, August 5 by Maxim Group. The firm earned “Buy” rating on Wednesday, November 23 by Maxim Group. Standpoint Research initiated it with “Buy” rating and $47.0 target in Monday, August 24 report. The rating was upgraded by Standpoint Research to “Buy” on Tuesday, December 15. The firm earned “Outperform” rating on Monday, November 28 by Leerink Swann. The firm earned “Mkt Perform” rating on Wednesday, November 23 by FBR Capital. The stock of Juno Therapeutics Inc (NASDAQ:JUNO) has “Sell” rating given on Thursday, June 8 by BTIG Research. Raymond James downgraded Juno Therapeutics Inc (NASDAQ:JUNO) on Tuesday, December 6 to “Mkt Perform” rating. Goldman Sachs initiated the shares of JUNO in report on Wednesday, November 18 with “Neutral” rating. The stock of Juno Therapeutics Inc (NASDAQ:JUNO) has “Outperform” rating given on Tuesday, August 18 by FBR Capital.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: